logo
Sarawak sees 700-800 new kidney failure cases annually, 4,800 now on dialysis, says SGH nephrologist

Sarawak sees 700-800 new kidney failure cases annually, 4,800 now on dialysis, says SGH nephrologist

Borneo Post11-05-2025
Dr Tan fields questions from reporters at the event. – Photo by Jude Toyat
KUCHING (May 11): Sarawak records between 700 and 800 new cases of kidney failure annually, with approximately 4,800 patients currently undergoing dialysis.
This alarming figure was revealed by Sarawak General Hospital (HUS) consultant nephrologist Dr Clare Tan Hui Hong during the launch of World Kidney Day 2025 at a shopping mall here today.
'Every year, we have about 700 to 800 new patients diagnosed with kidney failure who need to start dialysis. In total, we currently have around 4,800 patients on dialysis in Sarawak,' she told reporters after officiating the launch.
Dr Tan said the increasing number of kidney failure cases is concerning, emphasising the urgent need for preventive measures and greater public awareness.
'Dialysis centres are expanding. There are about 25 government-run dialysis facilities across Sarawak, with a new one set to open in Selangau Health Clinic by the end of the year. We also have around 12 charity-run centres, and more are in the pipeline,' she said.
Despite the growing number of dialysis centres, Dr Tan stressed that prevention remains far more critical than treatment.
'More than just focusing on dialysis, we must address the root issue — prevention. Raising awareness about kidney health is essential to slowing down the number of people progressing to kidney failure.'
She also cited national health survey data showing a worrying trend: the prevalence of chronic kidney disease (CKD) in Malaysia increased from 9.07 per cent in 2011 to 15.5 per cent in 2018 — rising from roughly one in 11 persons to one in six or seven.
Although no new nationwide surveys have been conducted since 2018, Dr Tan expressed hope that initiatives like World Kidney Day campaigns could reverse the upward trend.
This year's World Kidney Day carries the theme 'Detect Early, Protect Kidney Health', emphasising the importance of early detection and lifestyle interventions in reducing CKD cases.
'Let us work together to fight the epidemic of chronic kidney disease and to stop this epidemic,' Dr Tan urged.
Also present at the event were Kelab Rotary Kuching president Charlie Ong, COR Holder of NKF Kota Samarahan Dr Nurizaidah Ishak, and NKF Kota Samarahan regional unit coordinator Nur Ezzatul Sahadah Jelani. dialysis Dr Clare Tan kidney failure lead
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Not just bad posture: The hidden toll of scoliosis on health and life
Not just bad posture: The hidden toll of scoliosis on health and life

Sinar Daily

time5 days ago

  • Sinar Daily

Not just bad posture: The hidden toll of scoliosis on health and life

IT starts with a slouch, a shoulder higher than the other or a subtle curve that few notice. For individuals living with scoliosis, the condition goes beyond a curved spine. Often overlooked are the physical discomfort, restricted breathing, and emotional toll that quietly shape daily life. When people hear the word "scoliosis," most envision a curved back or uneven posture. But this spinal condition, which affects between 600,000 to 900,000 Malaysians, goes far beyond the visible, weaving its way into the lungs, gut and even mental health. The most common type, idiopathic scoliosis, often emerges in adolescence. Yet its impact can stretch far into adulthood. Less common forms like congenital (present from birth), neuromuscular (linked to disorders like cerebral palsy) and degenerative scoliosis (typically affecting older adults) add further complexity to the condition. While early diagnosis is key, awareness around scoliosis' broader effects remains limited, especially in Malaysia. Recognising this, Sunway Medical Centre Damansara (SMCD) is working to shed light on the hidden consequences of scoliosis through a more holistic approach to spine care; one that considers the full person, not just the curve. SMCD Consultant Orthopaedic and Spine Surgeon, Dr Tan Jin Aun, emphasised that scoliosis is more than just a spine issue. 'Secondary health effects tend to occur when curvature becomes severe, generally between 70 to 100 degrees. At this stage, the impact can vary depending on several factors of which include the age and overall health of the patient. 'The location of the curve and the type of scoliosis also influence whether respiratory or digestive complications arise,' he said. Understanding scoliosis: From detection to treatment Scoliosis may begin as a slight slouch or curve, but for those living with it, it often means enduring breathlessness, discomfort, emotional strain and quiet resilience. Photo: Edited via Canva For example, in moderate to severe cases, the spine's abnormal curve can distort the ribcage, pressing into the lungs. This can cause what is known as restrictive lung disease, where patients find it harder to take deep breaths. Dr Tan added, for thoracic curves, an angle of 70 degrees or more may start limiting lung expansion while a curve of more than 100 degrees can lead to severe pulmonary restriction and thus, difficulty in breathing or decreased effort tolerance. In the abdomen, similar curvature — especially lumbar curves beyond 90 degrees — can create pressure that leads to digestive issues such as bloating, acid reflux and constipation. These symptoms are frequently misdiagnosed or brushed off as unrelated gut problems. While physical discomfort is often acknowledged, the emotional and psychological toll of scoliosis frequently goes unnoticed. Living with a visible difference or chronic fatigue can affect more than body image, it can deeply impact mental well-being. 'In my experience, patients with mild scoliosis are generally healthy and often unaware of the condition. They usually do not present with anxiety or depression linked directly to scoliosis. 'That said, self-esteem issues do arise, especially in cases where bracing is required,' Dr Tan shared. Bracing is one of the primary non-surgical treatments for growing children with scoliosis. But while it can slow or halt curve progression, it comes with its own emotional challenges, especially when worn up to 23 hours a day over several years. Dr Tan mentioned it is important to prepare both the patient and their parents beforehand. 'The decision to move forward with bracing should always consider both physical outcomes and psychosocial wellbeing. There is no one-size-fits-all answer; it has to be a shared, well-informed decision,' Dr Tan emphasised. At SMCD, scoliosis care is not just about straightening a spine, it is about protecting quality of life. With a comprehensive, multidisciplinary approach, the hospital considers respiratory health, digestive function and mental wellness as part of the treatment journey. Diagnosis typically begins with a clinical evaluation and spinal X-rays to assess curvature type and severity. For patients whose spines have stopped growing, observation combined with physiotherapy and strength training may be sufficient. 'Patients with mild curvature – especially those who have reached skeletal maturity – are often managed conservatively. In these cases, we monitor the spine annually, refer for physiotherapy to improve posture and muscle strength and support families with accurate, realistic guidance,' Consultant Orthopaedic Surgeon (Spine Surgery and Interventional Pain Management) Dr Deepak Ajit Singh said. For those requiring surgery, SMCD leverages advanced tools such as spinal navigation and neuromonitoring to increase precision and reduce surgical risk. Yet, no matter the treatment, Dr Deepak stressed one crucial element. 'A simple spinal radiograph is often all that is needed to determine whether scoliosis is present. If we detect it early, we can plan the right course of action. Whether it is monitoring, bracing or in some cases, surgical correction. 'After all, it is not just about treating the spine but rather protecting long-term quality of life,' he added. In many cases, early signs of scoliosis — such as uneven shoulders, a tilted pelvis or a visible back hump — go unnoticed or are dismissed as poor posture. This leads to many Malaysians delaying a check-up until the condition is advanced. By highlighting the full scope of scoliosis' impact, SMCD hopes to encourage more timely intervention and foster a broader public understanding of what it truly means to live with the condition.

421 smiles restored: Miri's 21-year cleft surgery mission marks milestone as founder retires
421 smiles restored: Miri's 21-year cleft surgery mission marks milestone as founder retires

Borneo Post

time06-08-2025

  • Borneo Post

421 smiles restored: Miri's 21-year cleft surgery mission marks milestone as founder retires

Dr Philip (second right) places a traditional Kelabit bracelet on Dr Tan. Looking on from left are Lee and Dr Roland Dom Mattu, chief medical services officer at Selesa Pacific Hospital. MIRI (Aug 7): Over the past two decades, a total of 421 cleft lip and palate surgeries have been carried out here by a dedicated team of charity-minded medical professionals, transforming the lives of underprivileged patients. Cleft Lip and Palate Help Association Sarawak (Claphas) chairman Dato Dr Philip Raja said the initiative began in April 2004, spearheaded by eminent plastic surgeon Dr Kim Tan from Pantai Hospital. The inspiration came after Dr Tan met a Penan tour guide with an unrepaired cleft lip, a moment that deeply touched him and highlighted the treatment challenges faced by rural Sarawakians. Upon returning to Kuala Lumpur, Dr Tan collaborated with Rick Evans, then chairman of Columbia Asia Sdn Bhd, to launch a cleft lip and palate campaign in Sarawak. The first round of surgeries was supported by the Cleft Lip and Palate Association of Malaysia, with Columbia Asia Hospital Miri (now Selesa Pacific Hospital) providing facilities and logistical support. 'Since then, a total of 421 operations have been performed, and we are continuing this noble effort with the 25th Cleft Lip and Palate Charity Project this year,' Dr Phillip said, noting that six patients signed up for the latest round of surgeries which took place on Aug 4-6. He expressed gratitude to Dr Tan, anaesthetist Dr Joseph, and the team who have been involved since the beginning. 'They have changed the lives of 421 Sarawakians through this NGO (non-governmental organisation)-driven initiative,' he said. This year marks Dr Tan's last trip to Miri for the project, as he plans to retire after serving the cause for 21 consecutive years. State Transport Minister Dato Sri Lee Kim Shin also paid tribute to Dr Tan and his team, saying Sarawakians owe them a debt of gratitude for their noble efforts. 'These surgeries have transformed the lives of those who received them,' he said. 'I am happy that Dr Tan has roped in a successor to continue the project. Sarawak welcomes him to return and enjoy our tourist destinations after retirement.' Lee also urged the public to help identify potential candidates for future surgeries and to get in touch with Selesa Pacific Hospital for screening and arrangements. This year, the association received RM27,000 in public donations, a significant improvement from the early days when Dr Tan had to raise funds in Kuala Lumpur just to bring his team to Miri. Under Claphas criteria, recipients of the free surgeries must be Sarawakian children with household incomes of RM3,000 or less per month. The association and its partners are committed to helping these children regain their smiles, confidence, and access to a brighter future. 'This project teaches us about humility and the importance of doing our best. It could not have happened without the support of so many—our donors, medical team, hospital staff, and champions like Lee,' Dr Tan said during his farewell surgery session at Selesa Pacific Hospital yesterday. In a touching moment, one of Dr Tan's patients presented him with a bouquet of flowers, while the patient's mother donated RM500 to the project in honour of his tireless dedication. Claphas cleft lip Dr Philip Raja lead miri palate surgeries

Game-changing treatment for advanced prostate cancer
Game-changing treatment for advanced prostate cancer

The Star

time30-07-2025

  • The Star

Game-changing treatment for advanced prostate cancer

Prostate cancer is the third most common cancer among Malaysian men, with cases rising steadily since 2012. While it trails behind colorectal and lung cancer, it is still a significant concern. What's more worrying is that many cases are detected late. Early-stage prostate cancer is highly treatable, but late-stage cases are far more difficult to manage. What is prostate cancer? The disease begins when cells in the prostate – a small, ­walnut-sized gland below the bladder – start to grow uncontrollably. In its early stages, prostate ­cancer often causes no symptoms. But as the tumour grows, it can press against the urethra – the tube that carries urine – leading to changes in urination. Left untreated, the cancer can spread to nearby tissues, lymph nodes, or even the bones, making it more difficult to treat and manage. Yet, many men overlook the early signs. However, symptoms such as difficulty urinating, weak flow, or frequent trips to the bathroom at night may be early warning signs of prostate cancer. Sunway University consultant urologist and urologic oncologist Professor Dr Tan Guan Hee explains that these symptoms often go unnoticed or are mistaken for benign prostate conditions such as benign prostatic hyperplasia. 'Many men assume it's just part of getting older and delay seeing a doctor,' he says. 'Unfortunately, this means prostate cancer is often diagnosed at a later stage, when it's more difficult to treat.' As Malaysia's population continues to age, the number of prostate-related issues is expected to rise in tandem. Despite this, there is a general lack of awareness of the problem, minimal symptoms in early stages, and a cultural reluctance to seek help for intimate health issues. When prostate cancer is detected early, treatment options such as surgery or radiotherapy are often effective and potentially curative. However, late-stage prostate cancer, which may have already spread to bones or lymph nodes (metastasised), requires more advanced interventions. This is where radioligand therapy (RLT) offers new hope. Overcoming stigma One significant and often overlooked challenge in managing prostate cancer is cultural reluctance. Many patients delay seeking care due to embarrassment or denial, particularly Asian men, who may be more reserved about discussing health issues. Doctors often find that families bring in patients who have ignored symptoms for years. Prof Tan says: 'Addressing this cultural barrier requires greater public awareness, normalising conversations around men's health, and encouraging routine screening and early intervention.' Beyond individual awareness, family involvement plays a critical role in detecting early symptoms of prostate cancer and preventing critical outcomes. 'If children notice their father is frequently going to the toilet, they might realise something is amiss and encourage him to seek medical help,' he suggests. Treatment for prostate cancer depends on what stage the tumour is at. — Photos: Canva Precision treatment According to consultant clinical oncologist Dr Nik Muhd Aslan Abdullah, treatment for prostate cancer has come a long way since the 1990s. While surgery, radiotherapy and hormonal therapy remain standard options, recent advances in precision medicine have led to more targeted, effective treatments. Choosing the most appropriate treatment depends on several factors, including: > The stage of the cancer > The patient's age > Personal preferences > Underlying health conditions that may make certain treatments, such as surgery, unsuitable. 'In the past, our precision treatment options were quite limited. 'But today, we are guided by clearer staging and more accurate tools,' he says. Dr Nik outlines the four key stages that influence treatment strategy: > Stage 1: The tumour is confined to the prostate and involves no more than half of the gland. > Stage 2: The tumour remains within the prostate but is more advanced. > Stage 3: The tumour has grown beyond the prostate and may have reached nearby structures such as the seminal vesicles, rectum or bladder. > Stage 4: The cancer has spread to the lymph nodes or distant parts of the body, such as the bones. 'To determine the stage, we typically rely on three approaches: physical examination, blood tests, particularly for prostate-­specific antigen (PSA), and imaging. 'Conventional imaging includes computed tomography (CT) scans, magnetic resonance imaging (MRI), and bone scans,' he explains. However, these methods have their limitations. Dr Nik adds: 'They may miss early tumours or small areas of spread, and while blood tests are helpful, they cannot show the precise location of the cancer.' Sharper detection with PSMA PET-CT A key development is PSMA PET-CT imaging – a powerful diagnostic tool that combines positron emission tomography (PET) with CT to detect prostate-specific membrane antigen (PSMA), a protein found on most prostate cancer cells. 'About 80% of prostate cancer cells have a protein called PSMA on their surface,' explains Sunway University consultant nuclear medicine physician Associate Prof Dr Tan Teik Hin. 'We use this to both detect and treat cancer. The approach is simple: we treat what we see, and we see what we treat.' PSMA PET-CT works like a GPS for cancer cells. The CT maps the body's structure, while the PET scan lights up areas where PSMA-positive cancer cells are present. It can detect tumours as small as 0.3cm, far smaller than what conventional scans typically reveal. In an April 2020 ProPSMA study published in The Lancet , researchers found that this method was 27% more accurate than traditional imaging, often leading to significant changes in treatment planning. What is radioligand therapy or RLT? Once PSMA-positive cancer cells are identified, patients may be eligible for RLT. This treatment uses a radioactive compound that binds specifically to PSMA on cancer cells, delivering a precise dose of radiation directly to the tumour while sparing surrounding healthy tissue. Assoc Prof Teik Hin says: 'It's like sending a guided missile to destroy only the cancer cells. 'RLT is not entirely new. A similar concept – using radioactive iodine to treat thyroid cancer – has been in use for over 80 years. 'What's new is applying the same principle to prostate cancer using more advanced, highly specific radiotracers.' After treatment, a follow-up scan (SPECT-CT, a hybrid imaging technique that combines Single Photon Emission Computed Tomography and CT) is conducted to confirm that the radioligand successfully reached and treated the target. From left: Assoc Prof Teik Hin, Prof Tan and Dr Nik were the three medical professionals who led the roundtable discussion on RLT. — Handout Fewer side effects One of the greatest advantages of RLT is its specificity. Because the therapy targets only cancerous cells, it causes fewer side effects compared to systemic treatments like chemotherapy or hormonal therapy. Most patients tolerate it well, with mild side effects such as dry mouth, fatigue or nausea. More importantly, studies show that RLT can help delay disease progression, reduce symptoms like pain, and improve quality of life, especially for men with advanced or castration-resistant prostate cancer. While RLT is currently used mainly for patients with stage 4 prostate cancer who no longer respond to other treatments, ongoing clinical trials are exploring its use at earlier stages. PSMA PET-CT is also being studied for its ability to guide biopsies and detect cancer even before a formal diagnosis is made. 'Compared to systemic hormone therapy, which affects the entire body and can cause fatigue and mood changes, RLT offers a more targeted approach with fewer disruptions to daily life. 'We see a marked improvement in quality of life, and patients report less pain, more energy, and better sleep after the therapy,' says Assoc Prof Teik Hin. The treatment is available at government facilities such as the National Cancer Institute (IKN) in Putrajaya and Hospital Kuala Lumpur, as well as at several private hospitals. The cost of RLT varies depending on the hospital, the number of treatment cycles, and individual response to the treatment. As there is no fixed price, patients are encouraged to consult their medical team to discuss affordability and explore available financial support options. The three experts were discussing 'Size Matters in Prostate Cancer: Experts Highlight Advances to Close Critical Gaps in Care,' in a media roundtable held recently at a private hospital in Petaling Jaya, Selangor.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store